Viewing Study NCT02106156


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-02-23 @ 6:27 AM
Study NCT ID: NCT02106156
Status: COMPLETED
Last Update Posted: 2016-09-23
First Post: 2014-04-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists)
Sponsor:
Organization:

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: